medigraphic.com
SPANISH

Revista Médica Sinergia

Revista Médica Sinergia
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 01

<< Back Next >>

Revista Médica Sinergia 2021; 6 (01)

Infective endocarditis

Núñez GA, Campos QM, Molina CD
Full text How to cite this article

Language: Spanish
References: 15
Page: 1-13
PDF size: 200.33 Kb.


Key words:

endocarditis, fever, blood culture, anti-bacterial agents.

ABSTRACT

Infective endocarditis, is a rare disease that mainly affects native valves related to health care, occurs more frequently in adults over 60 years of age and in the male sex. Its predisposing factors over time have been changing, mainly in developed countries, displacing rheumatic fever. There are many microorganisms involved in the pathology and its distribution at a global level has remained stable, with the Gram-positive Cocos bacteria being the most frequent colonizers. For an infection to exist, there must be bacteremia under local conditions that allow endocardial proliferation and invasion. It should be suspected in all patients with fever associated with constitutional symptoms and risk factors for endocarditis, the diagnostic methods of choice are blood cultures and echocardiography respectively. The treatment is based on the eradication of the microorganism, antibiotic broad-spectrum therapy and surgery is reserved for cases that develop complications that can only be treated in the operating room. Antibiotic prophylaxis is only recommended in patients at risk.


REFERENCES

  1. Yang E, Frazee B,W. Infective Endocarditis. Emerg Med Clin N Am. [internet] 2018 [citado 22 febrero 2020] 36(4): 645-663. Disponible en: https://doi.org/10.1016/j.emc.2018.06.002

  2. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F et al. ESC Guidelines for the management of infective endocarditis. EHJ. [internet] 2015 [citado 22 febrero 2020] 36:3075-3123. Disponible en: https://doi.org/10.1093/eurheartj/ehv319

  3. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications. Circulation.[internet] 2015 [citado 23 febrero 2020]135: 1435-1486. Disponible en: https://doi.org/10.1161/CIR.0000000000000296

  4. Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG. Infective endocarditis. Nature Reviews Disease Primers. [internet] 2016 [citado 23 febrero 2020] 1;2:16059. Disponible en: 10.1038/nrdp.2016.59

  5. Conde mercado, JM.,Camacho Limas, CP.,Quintana Cuellar, M., De la Torre Saldaña, VA., Adán Brito, C. y Alonso Bello, CD.Endocarditis infecciosa. Rev Hosp Jua Mex, [internet] 2017 [citado 24 febrero 2020]. 84(3), 143-166. Doi: https://www.medigraphic.com/pdfs/juarez/ju-2017/ju173e.pdf

  6. García-Arribas,D., Olmos, C., Vivas D y Vilacosta.Endocarditis infecciosa. Medicine. [internet] 2017 [citado 25 febrero 2020] 12 (40), 2380-2395. Doi:https://www.medicineonline.es/es-endocarditis-infecciosa-articulo- S0304541217302160

  7. Klein M, Wang A. Infective endocarditis. J. Intensive Care Med. [internet] 2016 [citado 25 febrero 2020] 31(3): 151- 163. Disponible en: https://doi.org/10.1177%2F0885066614554906

  8. Karchmer A.W. Endocarditis Infecciosa. En: Jameson JL, Kasper DL, Longo DL, et al, editores. Harrison principios de medicina interna. Vol1. 20va ed. México: McGraw-Hill; 2018. p. 921-933.

  9. Muñoz P, Kestler M, De Alarcon A, Miro J.M, Bermejo J, Rodríguez-Abella H et al. Current Epidemiology and Outcome of Infective Endocarditis. Medicine (Baltimore) [internet] 2015 [citado 26 febrero 2020] 94(43): e1816. Disponible en: https://dx.doi.org/10.1097%2FMD.0000000000001816

  10. Baddour L.M, Freeman W.K, Suri R.M, Wilson W.R. Infecciones cardiovasculares. En: Mann D.L, Zipes D.P, Libby P, Bonow R.O, Tomaselli G.F, Braunwald E (Ed.). Braunwald tratado de cardiología. Vol 2. 11a ed. España: Elsevier, 2019 (pp.1483-1509).

  11. Olmos Blanco, C. Epidemiología y pronóstico del shock séptico en la endocarditis infecciosa. Tesis doctoral. [internet] 2015 [citado 26 febrero] Universidad Complutense de Madrid.

  12. Cahill T.J, Baddour L.M, Habib G, Hoen B, Salaun E, Petterson G.B et al. Callenges in Infective Endocarditis. JACC. [internet] 2016 [citado 1 marzo 2020] 69(3): 325-344. Disponible en: https://doi.org/10.1016/j.jacc.2016.10.066

  13. Fernadez-Gerlinger MP, Mainardi JL. Endocarditis infecciosa: del diagnóstico al tratamiento. EMC-Tratado de Medicina.[internet] 2016 [citado 1 marzo 2020] 20(4): 1-7. Disponible en: https://doi.org/10.1016/S1636- 5410(16)80656-X

  14. Vincent LL, Otto CM. Infective Endocarditis: Update on Epidemiology, Outcomes and Management. Current Cardiology Reports. [internet] 2018 [citado 1 marzo 2020] 16;20(10):86. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30117004

  15. Bolger AF. Preventing Endocarditis: No Rest for the Worrier.J Am Coll Cardiol. [internet] 2018 [citado 1 marzo 2020] 72(20): 2455-2456. Disponible en: https://doi.org/10.1016/j.jacc.2018.09.025




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Médica Sinergia. 2021;6